NCT03647423 - QUILT-3.091 NANT Chordoma Vaccine vs Radiation in Subjects With Unresectable Chordoma. | Biotech Hunter

Timeline

Start Date

August 31, 2018

Primary Completion Date

August 31, 2020

Study Completion Date

December 28, 2021

Conditions

ChordomaUnresectable Malignant Neoplasm

Interventions

BIOLOGICAL

Aldoxorubicin Hydrochloride

Aldoxorubicin Hydrochloride HCI

BIOLOGICAL

ALT-803

Recombinant human super agonist interleukin-15 (IL-15) complex

BIOLOGICAL

ETBX-051

Ad5 \[E1-, E2b-\]-Brachyury

BIOLOGICAL

ETBX-061

Ad5 \[E1-, E2b-\]-mucin 1 \[MUC1\]

BIOLOGICAL

GI-6301

Brachyury yeast

BIOLOGICAL

haNK

haNK™, NK-92 \[CD16.158V, ER IL-2\]

DRUG

Avelumab

injection

DRUG

Cetuximab

Injection

DRUG

Cyclophosphamide

Capsules

RADIATION

SBRT

Stereotactic body radiation therapy

Trial Locations (1)

Chan Soon-Shiong Institute for Medicine, El Segundo